No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr11:73641400-73672200 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
2 |
chr11:73663400-73670400 |
Weak transcription |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
3 |
chr11:73667400-73669800 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
4 |
chr11:73667400-73672000 |
Weak transcription |
HSMMtube |
muscle
|
5 |
chr11:73667600-73672200 |
Weak transcription |
HSMM |
muscle
|
6 |
chr11:73668000-73669200 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
7 |
chr11:73668000-73670000 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
8 |
chr11:73668200-73669800 |
Genic enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
9 |
chr11:73668400-73669200 |
Enhancers |
Primary B cells from cord blood |
blood
|
10 |
chr11:73668400-73669200 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
11 |
chr11:73668600-73669200 |
Enhancers |
Rectal Mucosa Donor 31 |
rectum
|
12 |
chr11:73668800-73669200 |
Bivalent Enhancer |
Placenta |
Placenta
|
13 |
chr11:73668800-73669200 |
Enhancers |
Gastric |
stomach
|
14 |
chr11:73668800-73669400 |
Enhancers |
Thymus |
Thymus
|
15 |
chr11:73668800-73672400 |
Weak transcription |
Osteobl |
bone
|
16 |
chr11:73669000-73669200 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
17 |
chr11:73669000-73669600 |
Active TSS |
Duodenum Mucosa |
Duodenum
|
18 |
chr11:73669000-73669800 |
Bivalent Enhancer |
Stomach Mucosa |
stomach
|
19 |
chr11:73669000-73669800 |
Enhancers |
K562 |
blood
|
20 |
chr11:73669000-73670600 |
Genic enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
21 |
chr11:73669000-73685800 |
Weak transcription |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|